查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2103013

血液凝固檢驗市場－策略分析與預測（2026-2035）

Coagulation Testing Market - Strategic Insights and Forecasts (2026-2035)
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計血液凝固檢驗市場將從 2026 年的 348,406 億美元成長到 2035 年的 475258 億美元，複合年成長率為 3.5%。

血液凝固檢驗透過測量血液的凝固能力來評估止血系統。這些試驗有助於診斷出血性疾病、監測抗凝血治療、評估術前出血風險，以及識別血栓症、栓塞和肝病等疾病。現代血液凝固檢驗系統結合了自動化分析儀、先進試劑和數位化檢測流程，能夠提供準確快速的結果。人們對血液凝固障礙的認知不斷提高、醫療保健成本不斷上漲以及技術的持續進步，正在推動醫院、診斷檢查室和門診中心廣泛採用血液凝固檢驗。

市場促進因素

血液和心血管疾病發生率不斷上升

血栓症、血友病、肝病、心血管疾病和其他凝血相關疾病的發生率不斷上升，持續推動血液凝固檢驗的需求。早期診斷有助於及時治療，並能減少與血液凝固障礙相關的併發症。

老年人口增加

隨著老年人口的成長，心血管疾病、血液凝固障礙以及需要定期進行凝血監測的慢性疾病的風險也在增加。這種人口趨勢導致全球範圍內相關檢測數量的持續成長。

對概念驗證測試的需求日益成長

照護現場血液凝固檢驗能夠實現快速診斷和即時臨床決策。醫療專業人員正擴大採用攜帶式血液凝固檢驗系統，以改善急診室、加護病房和門診部的病患管理。

技術進步

自動化凝血分析儀、先進感測器、智慧軟體和整合檢查室自動化系統的持續創新提高了檢測的準確性、效率和結果報告速度。這些進步正促使臨床檢查室更廣泛地採用這些技術。

市場限制因素

自動化系統高成本

全自動凝血分析儀需要對設備、維護和檢查室基礎設施進行大量投資，這可能會限制其在小規模醫療機構中的應用。

嚴格的監管要求

在將新的血液凝固檢驗產品推向市場之前，製造商必須遵守嚴格的品質標準、監管批准和檢查室認證要求。

發展中地區實施有限

在一些開發中國家對先進的血液凝固檢驗技術的認知不足、醫療基礎設施不足以及預算限制意味著市場滲透率仍然很低。

目錄

第1章執行摘要

  • 市場概述
  • 主要分析結果
  • 分析師意見
  • 策略建議

第2章 分析方法

  • 分析設計
  • 資料收集和分析方法
  • 市場規模估算
  • 預測模型
  • 先決條件和限制

第3章 全球血液凝固檢驗市場：概述、市場規模與未來預測

  • 市場定義和範圍
  • 止血和血液凝固檢驗概述
  • 產業變化
  • 主要市場趨勢
  • 市場規模分析：實際成果值
  • 市場預測
  • 與血液凝固檢驗相關的疾病負擔和臨床需求
  • 測試數量分析
  • 患者人口統計分析
  • 臨床應用概述
  • 檢查室工作流程和測試流程

第4章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰

第5章 行業情勢

  • 產業價值鏈分析
  • 定價分析
  • 還款狀態

第6章：創新趨勢

  • 凝血診斷領域的新興技術
  • 產品創新
  • 管道分析
  • 技術藍圖
  • 數位實驗室的自動化和整合
  • 人工智慧與數據分析的融合

第7章 監理情勢

  • 法律規範
  • 核准流程
  • 合規要求

第8章 全球血液凝固檢驗市場：展望分析

  • 分析：依產品類型
  • 分析：按測試類型
  • 分析：按操作類型
  • 分析：透過應用
  • 分析：按最終用戶

第9章 全球血液凝固檢驗市場：細分市場分析

  • 依產品
    • 裝置
    • 試劑
    • 耗材和配件
  • 按測試類型
    • 血液常規檢查（CBC）
    • 因子V檢測法
    • 纖維蛋白原濃度
    • 血小板計數
    • 其他
  • 透過操作方法
    • 全自動凝血分析儀
    • 半自動凝血分析儀
  • 透過使用
    • 疾病檢測
    • 抗凝血治療監測
    • 術前評估
    • 其他
  • 最終用戶
    • 醫院
    • 臨床實驗室
    • 其他

第10章 全球血液凝固檢驗市場：區域分析

  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第11章 全球血液凝固檢驗市場：國家分析

  • 美國
  • 加拿大
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 日本
  • 中國
  • 印度
  • 韓國
  • 澳洲
  • 巴西
  • 墨西哥
  • 沙烏地阿拉伯
  • 南非

第12章 競爭格局

  • 市佔率分析
  • 策略趨勢
  • 企業合併、合作與聯盟
  • 新產品發布

第13章：公司簡介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Medtronic plc
  • Siemens AG
  • Werfen Life Group
  • Stago Group
  • Haemonetics Corporation
  • Terumo Corporation
  • HORIBA, Ltd.

第14章：全球血液凝固檢驗市場：商業預測分析

第15章 投資與資金籌措分析

  • 創業投資趨勢
  • 政府資金
  • 研發投資

第16章：未來展望

  • 主要成長機遇
  • 未來產業趨勢
簡介目錄
Product Code: KSI-009017

The Coagulation Testing Market is expected to grow at a CAGR of 3.5% from a market value of USD 3,484.06 million in 2026 to USD 4,752.58 million in 2035.

Coagulation testing is performed to evaluate the hemostasis system by measuring the ability of blood to clot properly. These tests help diagnose bleeding disorders, monitor anticoagulant therapy, assess preoperative bleeding risks, and identify conditions such as thrombosis, embolism, and liver disease. Modern coagulation testing systems combine automated analyzers, advanced reagents, and digital laboratory workflows to deliver accurate and timely results. Growing awareness of blood clotting disorders, increasing healthcare expenditure, and continuous technological advancements are driving the adoption of coagulation testing across hospitals, diagnostic laboratories, and ambulatory care centers.

Market Drivers

Rising Prevalence of Blood and Cardiovascular Disorders

The increasing incidence of thrombosis, hemophilia, liver disease, cardiovascular disorders, and other coagulation-related conditions continues to drive demand for coagulation testing. Early diagnosis enables timely treatment and reduces complications associated with abnormal blood clotting.

Growing Geriatric Population

The expanding elderly population is more susceptible to cardiovascular diseases, blood clotting disorders, and chronic illnesses requiring regular coagulation monitoring. This demographic trend continues to increase testing volumes globally.

Increasing Demand for Point-of-Care Testing

Point-of-care coagulation testing allows faster diagnosis and immediate clinical decision-making. Healthcare providers are increasingly adopting portable coagulation testing systems to improve patient management in emergency departments, intensive care units, and outpatient settings.

Technological Advancements

Continuous innovation in automated coagulation analyzers, advanced sensors, intelligent software, and integrated laboratory automation has improved testing accuracy, efficiency, and turnaround times. These developments are supporting wider adoption across clinical laboratories.

Market Restraints

High Cost of Automated Systems

Fully automated coagulation analyzers require substantial investment in equipment, maintenance, and laboratory infrastructure, which may limit adoption among smaller healthcare facilities.

Stringent Regulatory Requirements

Manufacturers must comply with rigorous quality standards, regulatory approvals, and laboratory accreditation requirements before introducing new coagulation testing products into the market.

Limited Adoption in Developing Regions

Lack of awareness regarding advanced coagulation testing technologies, inadequate healthcare infrastructure, and budget constraints continue to slow market penetration in several developing countries.

Market and Technology Insights

The global coagulation testing market can be segmented by Test Type, End Users, and Geography.

By test type, the market includes:

  • Prothrombin Time (PT) Testing
  • Fibrinogen Testing
  • Activated Clotting Time (ACT) Testing
  • Platelet Function Tests
  • Other Coagulation Tests

Prothrombin Time testing remains one of the most widely performed coagulation tests due to its routine use in monitoring anticoagulant therapy and evaluating clotting function.

By end users, the market comprises:

  • Hospitals and Clinics
  • Diagnostic Centres
  • Ambulatory Care Centres

Hospitals and clinics account for the largest share owing to increasing patient admissions, surgical procedures, and routine coagulation monitoring.

Market Trends

Several technological developments continue shaping the coagulation testing market.

Key trends include:

  • Expansion of automated coagulation analyzers.
  • Growing adoption of point-of-care coagulation testing.
  • Increasing laboratory automation.
  • Development of intelligent workflow management systems.
  • Introduction of next-generation hemostasis analyzers.
  • Growing focus on anticoagulant therapy monitoring.
  • Improved reagent performance and testing efficiency.

Regional Insights

North America holds the largest share of the coagulation testing market due to advanced healthcare infrastructure, widespread laboratory automation, strong adoption of innovative diagnostic technologies, and high prevalence of cardiovascular diseases.

Europe continues to experience steady market growth through modernization of clinical laboratories, increasing healthcare expenditure, and rising awareness regarding blood clotting disorders.

Asia-Pacific is expected to witness significant growth owing to improving healthcare infrastructure, increasing healthcare investments, expanding diagnostic laboratory networks, and growing awareness of coagulation testing across emerging economies.

The Middle East & Africa and South America continue to strengthen diagnostic capabilities through healthcare modernization and increased investment in laboratory services.

Competitive Landscape

The market remains competitive, with manufacturers focusing on automation, innovative analyzers, advanced reagents, and laboratory workflow optimization.

Major companies include:

  • Abbott
  • Diagnostica Stago S.A.S.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific
  • Enzyme Research Laboratories Ltd.

Companies continue investing in automated hemostasis systems, advanced coagulation reagents, and strategic collaborations to strengthen their market positions.

Future Outlook

The future of the coagulation testing market will be driven by increasing demand for automated laboratory solutions, expanding adoption of point-of-care diagnostics, technological innovation, and growing awareness regarding blood clotting disorders. Continued improvements in analyzer performance, laboratory automation, and intelligent diagnostic workflows are expected to enhance testing efficiency while supporting better patient outcomes.

Conclusion

The Global Coagulation Testing Market is expected to witness steady growth, supported by increasing prevalence of blood disorders, cardiovascular diseases, expanding geriatric populations, and continuous technological innovation. Although high equipment costs and regulatory requirements remain challenges, advances in automation and diagnostic technologies are expected to create significant opportunities for manufacturers, healthcare providers, and diagnostic laboratories.

Key Benefits of this Report

  • Comprehensive assessment of the global coagulation testing market.
  • Detailed evaluation of test types, laboratory technologies, and emerging innovations.
  • Analysis of market dynamics, competitive strategies, and future opportunities.
  • Insights into laboratory automation, point-of-care testing, and hemostasis diagnostics.
  • Valuable resource for diagnostic manufacturers, healthcare providers, laboratories, researchers, investors, and policymakers.

What Businesses Use Our Reports For

Market opportunity assessment, product portfolio planning, competitive benchmarking, laboratory modernization strategy, commercialization planning, partnership evaluation, investment analysis, regulatory planning, and long-term strategic decision-making.

Report Coverage

  • Historical data from 2021 to 2024, Base Year 2025, and Forecast Period 2026 to 2031
  • Comprehensive analysis by Test Type, End Users, and Geography
  • Evaluation of market dynamics, technological innovation, laboratory automation, competitive landscape, and future growth opportunities
  • Assessment of Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Platelet Function Tests, coagulation analyzers, diagnostic laboratories, hospitals, ambulatory care centres, and emerging hemostasis testing technologies.

TABLE OF CONTENTS

1. Executive Summary

  • 1.1 Market Snapshot
  • 1.2 Key Findings
  • 1.3 Analyst Insights
  • 1.4 Strategic Recommendations

2. Research Methodology

  • 2.1 Research Design
  • 2.2 Data Collection Methodology
  • 2.3 Market Size Estimation
  • 2.4 Forecasting Model
  • 2.5 Assumptions & Limitations

3. Global Coagulation Testing Market Overview, Size & Forecast

  • 3.1 Market Definition & Scope
  • 3.2 Overview of Hemostasis and Coagulation Testing
  • 3.3 Industry Evolution
  • 3.4 Key Market Trends
  • 3.5 Historical Market Size Analysis (2021-2025)
  • 3.6 Market Forecast (2026-2035)
  • 3.7 Disease Burden and Clinical Need for Coagulation Testing
  • 3.8 Testing Volume Analysis
  • 3.9 Patient Population Analysis
  • 3.10 Clinical Application Overview
  • 3.11 Laboratory Workflow and Testing Pathway

4. Market Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Market Challenges

5. Industry Landscape

  • 5.1 Industry Value Chain Analysis
  • 5.2 Pricing Analysis
  • 5.3 Reimbursement Landscape

6. Innovation Landscape

  • 6.1 Emerging Technologies in Coagulation Diagnostics
  • 6.2 Product Innovation
  • 6.3 Pipeline Analysis
  • 6.4 Technology Roadmap
  • 6.5 Automation and Digital Laboratory Integration
  • 6.6 Artificial Intelligence and Data Analytics Integration

7. Regulatory Landscape

  • 7.1 Regulatory Framework
  • 7.2 Approval Pathways
  • 7.3 Compliance Requirements

8. Global Coagulation Testing Market Landscape Analysis

  • 8.1 Analysis by Product Type
  • 8.2 Analysis by Test Type
  • 8.3 Analysis by Operating Mode
  • 8.4 Analysis by Application
  • 8.5 Analysis by End User

9. Global Coagulation Testing Market Segment Analysis (2021-2035)

  • 9.1 By Product
    • 9.1.1 Instruments
    • 9.1.2 Reagents
    • 9.1.3 Consumables & Accessories
  • 9.2 By Test Type
    • 9.2.1 Complete Blood Count (CBC)
    • 9.2.2 Factor V Assay
    • 9.2.3 Fibrinogen Level
    • 9.2.4 Platelet Count
    • 9.2.5 Others
  • 9.3 By Operating Mode
    • 9.3.1 Automatic Coagulation Analyzers
    • 9.3.2 Semi-Automatic Coagulation Analyzers
  • 9.4 By Application
    • 9.4.1 Disease Detection
    • 9.4.2 Monitoring Anticoagulant Therapy
    • 9.4.3 Pre-Surgical Assessments
    • 9.4.4 Others
  • 9.5 By End User
    • 9.5.1 Hospitals
    • 9.5.2 Clinical Laboratories
    • 9.5.3 Others

10. Global Coagulation Testing Market Geographical Analysis (2021-2035)

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia-Pacific
  • 10.4 South America
  • 10.5 Middle East & Africa

11. Global Coagulation Testing Market Country Analysis (2021-2035)

  • 11.1 United States
  • 11.2 Canada
  • 11.3 Germany
  • 11.4 United Kingdom
  • 11.5 France
  • 11.6 Italy
  • 11.7 Spain
  • 11.8 Japan
  • 11.9 China
  • 11.10 India
  • 11.11 South Korea
  • 11.12 Australia
  • 11.13 Brazil
  • 11.14 Mexico
  • 11.15 Saudi Arabia
  • 11.16 South Africa

12. Competitive Landscape

  • 12.1 Market Share Analysis
  • 12.2 Strategic Developments
  • 12.3 Mergers & Acquisitions, Partnerships & Collaborations
  • 12.4 Product Launches

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Company Overview
    • 13.1.2 Financials
    • 13.1.3 Product Portfolio
    • 13.1.4 Recent Developments
  • 13.2 F. Hoffmann-La Roche Ltd
  • 13.3 Sysmex Corporation
  • 13.4 Medtronic plc
  • 13.5 Siemens AG
  • 13.6 Werfen Life Group
  • 13.7 Stago Group
  • 13.8 Haemonetics Corporation
  • 13.9 Terumo Corporation
  • 13.10 HORIBA, Ltd.

14. Global Coagulation Testing Market Commercial Forecast Analysis

  • 14.1 Coagulation Analyzers
  • 14.2 Routine Coagulation Assays
  • 14.3 D-Dimer Testing
  • 14.4 Viscoelastic Testing Systems
  • 14.5 Platelet Function Testing Systems
  • 14.6 Point-of-Care Coagulation Testing Systems
  • 14.7 Specialized Coagulation Assays

15. Investment & Funding Analysis

  • 15.1 Venture Capital Trends
  • 15.2 Government Funding
  • 15.3 R&D Investments

16. Future Outlook

  • 16.1 Key Growth Opportunities
  • 16.2 Future Industry Trends